Table 4.
HRs and 95% CIs for sleep timing (bedtime, wake-up time, sleep midpoint) associated with CVD mortality.
| Sleep Timing | SHHS | MrOS | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariable Analysis | Multivariable Adjusted | Univariable Analysis | Multivariable Adjusted | |||||
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
| Bedtime | ||||||||
| > 12:00 am | 2.16 (1.62–2.87) | <0.001 | 1.70 (1.24–2.34) | .001 | 1.10 (0.78–1.56) | 0.574 | 1.26 (0.85–1.86) | .247 |
| ≤ 10:00 pm | 1.49 (1.14–1.93) | 0.003 | 1.28 (0.96–1.71) | .098 | 1.37 (1.14–1.65) | 0.001 | 1.15 (0.94–1.42) | .179 |
| 10:01 pm–12:00 am | 1 | 1 | 1 | 1 | ||||
| Wake-up time | ||||||||
| > 8:00 am | 2.12 (1.50–3.02) | <0.001 | 1.25 (0.85–1.84) | .257 | 1.73 (1.33–2.24) | <0.001 | 1.19 (0.88–1.60) | .261 |
| ≤ 6:00 am | 1.00 (0.79–1.25) | 0.972 | 1.17 (0.91–1.51) | .226 | 1.03 (0.84–1.26) | 0.775 | 1.25 (1.00–1.56) | .052 |
| 6:01 am–8:00 am | 1 | 1 | 1 | 1 | ||||
| Sleep midpoint | ||||||||
| > 4:00 am | 2.08 (1.51–2.88) | <0.001 | 1.43 (1.01–2.01) | .041 | 1.54 (1.13–2.08) | 0.006 | 1.27 (0.90–1.79) | .178 |
| ≤ 2:00 am | 1.05 (0.81–1.38) | 0.704 | 1.10 (0.84–1.46) | .486 | 1.31 (1.07–1.60) | 0.008 | 1.36 (1.10–1.68) | .004 |
| 2:01 am–4:00 am | 1 | 1 | 1 | 1 | ||||
Multivariable adjusted by age, sex, race, BMI, smoking status, alcohol use, diabetes mellitus, hypertension, AHI, T90, benzodiazepine use, lipid-lowering medication use, history of MI, CHF, stroke/cerebrovascular disease, COPD, and chronic bronchitis, insomnia symptom, and sleep duration.
AHI = apnea-hypopnea index, BMI = body mass index, CHF = congestive heart failure, 95% CI = 95% confidence interval, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, HR = hazard ratio, MI = myocardial infarction, MrOS = Osteoporotic Fractures in Men Study, SHHS = Sleep Heart Health Study, T90 = percent time below oxygen desaturation 90%.